Mass spectrometry (MS) has become a pivotal analytical tool across various scientific disciplines due to its ability to provide detailed molecular information with high sensitivity and specificity. MS plays a crucial role in various fields, including drug discovery and development, proteomics, metabolomics, environmental analysis, and clinical diagnostics and Forensic science. In this article we are discussing the application of MS across the diverse scientific disciplines by focusing on some classical examples from each field of application. As the technology continues to evolve, it promises to unlock new possibilities in scientific research and practical applications, cementing its position as an essential tool in modern analytical science.
KurilAK. Navigating mass spectrometry: a comprehensive guide to basic concepts and techniques. Int J Sci Dev Res2024; 9: 35–47.
2.
KhalikovaMJirešJHoráčekO, et al.What is the role of current mass spectrometry in pharmaceutical analysis?Mass Spectrom Rev2024; 43: 560–609.
3.
LiX. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing. J Pharm Biomed Anal2023; 234: 115581.
4.
DeschampsECalabreseVSchmitzI, et al.Advances in ultra-high-resolution mass spectrometry for pharmaceutical analysis. Molecules2023; 28: 2061.
5.
BaghelUSSinghASinghD, et al.Application of mass spectroscopy in pharmaceutical and biomedical analysis. In Spectroscopic analyses—developments and applications, InTech, 2017. doi:10.5772/intechopen.70655.
6.
PatelP, et al.A review on the development of novel heterocycles as α-glucosidase inhibitors for the treatment of type-2 diabetes mellitus. Med Chem (Los Angeles)2024; 20: 503–536.
7.
PatelM, et al.Prominent targets for cancer care: immunotherapy perspective. Curr Cancer Ther Rev2023; 19: 298–317.
LeeJ.-Y.KimS. K.LeeK. S. J., et al. “The application of mass spectrometry in drug metabolism and pharmacokinetics,” In KimJKKimJKPackC.-G (eds), Advanced imaging and bio techniques for convergence science, Singapore: Springer Singapore, 2021, pp. 533–550.
10.
CuyckensF. Mass spectrometry in drug metabolism and pharmacokinetics: current trends and future perspectives. Rapid Commun Mass Spectrom2019; 33: 90–95.
11.
TheodoridisGGikaHRafteryD, et al.Ensuring fact-based metabolite identification in liquid chromatography–mass spectrometry-based metabolomics. Anal Chem2023; 95: 3909–3916.
12.
LynnK-S, et al.Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information. Anal Chem2015; 87: 2143–2151.
13.
PrasadBGargATakwaniH, et al.Metabolite identification by liquid chromatography-mass spectrometry. TrAC, Trends Anal Chem2011; 30: 360–387.
14.
XiaoJFZhouBRessomHW. Metabolite identification and quantitation in LC-MS/MS-based metabolomics. TrAC, Trends Anal Chem2012; 32: 1–14.
15.
AlseekhS, et al.Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat Meth2021; 18: 747–756.
16.
JiaZQiuQHeR, et al.Identification of metabolite interference is necessary for accurate LC-MS targeted metabolomics analysis. Anal Chem2023; 95: 7985–7992.
17.
ChavanBB, et al.In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites. J Pharm Biomed Anal2018; 157: 59–74.
18.
Johnsi RaniPVishnuvardhanCNimbalkarRD, et al.Metabolite characterization of ambrisentan, in in vitro and in vivo matrices by UHPLC/QTOF/MS/MS: detection of glutathione conjugate of epoxide metabolite evidenced by in vitro GSH trapping assay. J Pharm Biomed Anal2018; 155: 320–328.
19.
LiC-XLiangJSongY, et al.Structural characterization of the metabolites of orally ingested hederasaponin B, a natural saponin that is isolated from Acanthopanax senticosus leaves by liquid chromatography–mass spectrometry. J Pharm Biomed Anal2021; 197: 113929.
20.
KuznetsovI, et al.Three-dimensional nanoscale molecular imaging by extreme ultraviolet laser ablation mass spectrometry. Nat Commun2015; 6: 6944.
21.
GranborgJRHandlerAMJanfeltC. Mass spectrometry imaging in drug distribution and drug metabolism studies – principles, applications and perspectives. TrAC, Trends Anal Chem2022; 146: 116482.
22.
SrinivasuBYArumugaperumalAMitraA, et al.Effect of nanoparticle exposure in a living system: probed by quantification of fetuin-B in plasma proteome and kidney tissue imaging using MALDI imaging mass spectrometry in a rat model. J Nanopart Res2021; 23: 125.
23.
CerrutiCDTouboulDGuérineauV, et al.MALDI imaging mass spectrometry of lipids by adding lithium salts to the matrix solution. Anal Bioanal Chem2011; 401: 75–87.
24.
HofstadlerSASannes-LoweryKA. Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes. Nat Rev Drug Discov2006; 5: 585–595.
25.
DueñasMEPeltier-HeapRELeveridgeM, et al.Advances in high-throughput mass spectrometry in drug discovery. EMBO Mol Med2023; 15: 1–15.
26.
KurilAKSaravananKSubbappaPK. Analytical considerations for characterization of generic peptide product: a regulatory insight. Anal Biochem2024; 694: 115633. https://doi.org/10.1016/j.ab.2024.115633
27.
Janin-BussatM.-C, et al.Structural characterization of antibodies by mass spectrometry. In: Antibody engineering, Berlin, Heidelberg: Springer, 2010, pp. 613–634.
28.
Srebalus BarnesCALimA. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev2007; 26: 370–388.
29.
PengWPronkerMFSnijderJ. Mass spectrometry-based de novo sequencing of monoclonal antibodies using multiple proteases and a dual fragmentation scheme. J Proteome Res2021; 20: 3559–3566.
30.
KurilAKSaravananK. High-throughput method for peptide mapping and amino acid sequencing for calcitonin salmon in calcitonin salmon injection using ultra high performance liquid chromatography–high resolution mass spectrometry (UHPLC-HRMS) with the application of bioinformatic tools. J Pharm Biomed Anal2024; 243: 116094.
31.
GauBC, et al.Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2. Sci Rep2023; 13: 9038.
32.
WangPWilsonSR. Mass spectrometry-based protein identification by integrating de novo sequencing with database searching. BMC Bioinform2013; 14: S24.
33.
HughesCMaBLajoieGA. De novo sequencing methods in proteomics. Methods Mol Biol2010; 604: 105–121.
34.
KurilAK. Differential scanning calorimetry: a powerful and versatile tool for analyzing proteins and peptides. J Pharm Res Int2024; 36: 179–187.
35.
DollSBurlingameAL. Mass spectrometry-based detection and assignment of protein posttranslational modifications. ACS Chem Biol2015; 10: 63–71.
36.
LiuXRRempelDLGrossML. Protein higher-order-structure determination by fast photochemical oxidation of proteins and mass spectrometry analysis. Nat Protoc2020; 15: 3942–3970.
37.
KurilAKSaravananK. Method development and validation for the determination of higher molecular weight species of calcitonin salmon in calcitonin salmon injection by high-performance size exclusion chromatography. Int J Pharm Sci Drug Res2024; 16: 1–7.
38.
PatelBA. Permeation enhancement and advanced strategies: a comprehensive review of improved topical drug delivery. Int Res J Moderniz Eng Technol Sci2024; 6: 6691–6702.
39.
PatelBA. Niosomes: a promising approach for advanced drug delivery in cancer treatment. Int Res J Moderniz Eng Technol Sci2024; 6: 2747–2752.
40.
VashiA. Cell-based in vitro models: emerging technologies for enhanced drug permeability prediction. Int Res J Moderniz Eng Technol Sci2024; 6: 6389–6397.
41.
VashiA. Nanoparticle based liposomes for drug delivery: a review of physicochemical considerations. Int Res J Moderniz Eng Technol Sci2024; 6: 9028–9038.
42.
VashiAS. Renewable resource-based polymers and properties of interpenetrating polymer networks based on castor oil. Int Res J Moderniz Eng Technol Sci2024; 6: 7074–7079.
43.
PengYChenXSatoT, et al.Purification and high-resolution top-down mass spectrometric characterization of human salivary α-amylase. Anal Chem2012; 84: 3339–3346.
44.
TsaiPLChenS-FHuangSY. Mass spectrometry-based strategies for protein disulfide bond identification. Rev Anal Chem2013; 32: 257–268.
45.
ChaturvediSBawakeSSharmaN. Recent advancements in disulfide bridge characterization: insights from mass spectrometry. Rapid Commun Mass Spectrom2024; 38.
46.
KurilAKVashiA. Identifying trending issues in assay of peptide therapeutics during stability study. Am J Biomed Sci Res2024; 22: 501–504.
47.
NowakC, et al.Forced degradation of recombinant monoclonal antibodies: a practical guide. MAbs2017; 9: 1217–1230.
48.
WangD, et al.Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry. Anal Chem2015; 87: 914–921.
49.
ParitalaSTSharmaNShahRP. A comprehensive study on the identification and characterization of degradation products of lipoglycopeptide Dalbavancin using LC and LC-HRMS/MS. J Pept Sci2024; 30.
Ankur VashiAKK. Cisplatin: a beacon of hope in cancer treatment—unveiling the potent alkylating antineoplastic agent. Eur J Pharm Med Res2024; 11: 197–203.
52.
LiuYRomijnEPVerniestG, et al.Mass spectrometry-based structure elucidation of small molecule impurities and degradation products in pharmaceutical development. TrAC, Trends Anal Chem2019; 121: 115686.
53.
ThomasS, et al.Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MSn. Analyst2012; 137: 3571.
54.
DhimanV, et al.Stress degradation study on entrectinib and characterization of its degradation products using HRMS and NMR. J Pharm Biomed Anal2022; 208: 114459.
SandhiyaV, et al.Iron oxide nanoparticles: a mighty pioneering diagnostic tool but is it really safe for carcinoma and neurodegenerative diseases? In Toxicity of nanoparticles—recent advances and new perspectives, IntechOpen, 2024.
58.
ManickamV, et al.Green fabrication of silver nanoparticles and it’s in vitro anti-bacterial, anti-biofilm, free radical scavenging and mushroom tyrosinase efficacy evaluation. Inorg Chem Commun2024; 162: 112199.
59.
KurilAKSaravananK. Particle matter determination in biosimilar parenteral product by the application of dynamic light scattering (DLS) followed by statistical evaluation. Eur J Parenteral Pharm Sci2024; 29: 1–13.
60.
PA. Applications of LC−MS in Environmental Chemistry. Series: Journal of Chromatography Library, Vol. 59. Edited by BarcelóD.(CID-CSIC). Elsevier: Amsterdam.1996. xxii + 543 pp. $281.25. ISBN 0-444-82067-1.,” J Am Chem Soc, vol. 119, no. 22, p. 5276, Jun. 1997.
Bosch-OreaCSanchísJFarréM. Analysis of highly polar marine biotoxins in seawater by hydrophilic interaction liquid chromatography coupled to high resolution mass spectrometry. MethodsX2021; 8: 101370.
63.
HayesPL. Quantification of the sources and composition of particulate matter by field-deployable mass spectrometry: implications for air quality and public health. Analyst2017; 142: 687–690.
64.
ZhangX, et al.Chemical characterization of submicron aerosol particles during wintertime in a northwest city of China using an aerodyne aerosol mass spectrometry. Environ Pollut2017; 222: 567–582.
65.
ChenW, et al.Onsite identification and spatial distribution of air pollutants using a drone-based solid-phase microextraction array coupled with portable gas chromatography-mass spectrometry via continuous-airflow sampling. Environ Sci Technol2022; 56: 17100–17107.
66.
JacksonGPBarkettMA. Forensic mass spectrometry: scientific and legal precedents.J Am Soc Mass Spectrom2023; 34: 1210–1224.
BloomMBSiscoELurieIS. Development and validation of a rapid GC–MS method for seized drug screening. Forensic Chem2023; 33: 100479.
69.
SiscoEVerkouterenJStaymatesJ, et al.Rapid detection of fentanyl, fentanyl analogues, and opioids for on-site or laboratory based drug seizure screening using thermal desorption DART-MS and ion mobility spectrometry. Forensic Chem2017; 4: 108–115.
70.
ChiangC-HLeeH-HChenB-H, et al.Using ambient mass spectrometry and LC–MS/MS for the rapid detection and identification of multiple illicit street drugs. J Food Drug Anal2019; 27: 439–450.
ScheubertKHufskyFBöckerS. Computational mass spectrometry for small molecules. J Cheminform2013; 5: 12.
73.
DührkopK, et al.SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information. Nat Meth2019; 16: 299–302.
74.
MaYKindTYangD, et al.MS2Analyzer: a software for small molecule substructure annotations from accurate tandem mass spectra. Anal Chem2014; 86: 10724–10731.
75.
ShatskyMDrorOSchneidman-DuhovnyD, et al.Bioinfo3d: a suite of tools for structural bioinformatics.Nucleic Acids Res2004; 32: W503–W507.
KaklamanosGApreaETheodoridisG, Mass spectrometry: principles and instrumentation. In: CaballeroBFinglasPMToldráF (eds) Encyclopedia of food and health, Oxford: Academic Press, 2016, pp. 661–668.
